Follow-up of lesions with equivocal radiotracer uptake on PSMA-targeted PET in patients with prostate cancer: predictive values of the PSMA-RADS-3A and PSMA-RADS-3B categories

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Journal of Nuclear Medicine, 60, 4, S. 511-516

Event
Veröffentlichung
(where)
Augsburg
(who)
Universität Augsburg
(when)
2019
Event
Veröffentlichung
(where)
New York, NY
(who)
Society of Nuclear Medicine
(when)
2019
Creator
Yin, Yafu
Wolf, Herta
Higuchi, Takahiro
Lapa, Constantin Frederik Victor
Pienta, Kenneth J.
Pomper, Martin G.
Gorin, Michael A.
Rowe, Steven P.

DOI
10.2967/jnumed.118.217653
URN
urn:nbn:de:bvb:384-opus4-629859
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:51 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

Time of origin

  • 2019

Other Objects (12)

Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer

Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer

Unfolding the cardioprotective potential of sigma-1 receptor-directed molecular imaging

Unfolding the cardioprotective potential of sigma-1 receptor-directed molecular imaging

Hematotoxicity and nephrotoxicity in prostate cancer patients undergoing radioligand therapy with [\(^177}\)Lu]Lu-PSMA I&T

Hematotoxicity and nephrotoxicity in prostate cancer patients undergoing radioligand therapy with [\(^177}\)Lu]Lu-PSMA I&T

Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on \(^18}\)F-DCFPyL PET/CT Imaging

Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on \(^18}\)F-DCFPyL PET/CT Imaging

Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on 18F-DCFPyL PET/CT imaging

Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on 18F-DCFPyL PET/CT imaging

A Voice From the Past: Re-Discovering the Virchow Node with PSMA-targeted \(^18}\)F-DCFPyL PET Imaging

A Voice From the Past: Re-Discovering the Virchow Node with PSMA-targeted \(^18}\)F-DCFPyL PET Imaging

A Voice From the Past: Re-Discovering the Virchow Node with PSMA-targeted \(^18}\)F-DCFPyL PET Imaging

A Voice From the Past: Re-Discovering the Virchow Node with PSMA-targeted \(^18}\)F-DCFPyL PET Imaging

Semiquantitative parameters in PSMA-targeted PET imaging with [18F]DCFPyL: impact of tumor burden on normal organ uptake

Semiquantitative parameters in PSMA-targeted PET imaging with [18F]DCFPyL: impact of tumor burden on normal organ uptake

177Lu-rhPSMA-10.1 induces tumor response in a patient with mCRPC after PSMA-directed radioligand therapy with 177Lu-PSMA-I AND T

177Lu-rhPSMA-10.1 induces tumor response in a patient with mCRPC after PSMA-directed radioligand therapy with 177Lu-PSMA-I AND T

Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]

Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]

Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia

Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia

Related objects